CJASN:低钙透析液或增心脏骤停风险

2013-05-18 姜珊 编译 中国医学论坛报

  美国一项研究表明,低钙透析液、血清-透析液钙浓度梯度较大与心脏骤停风险增加相关。该论文发表于《美国肾脏病学会临床杂志》[Clin J Am Soc Nephrol 2013,8(5):797]。   该研究纳入血液透析者中510例心脏骤停者及1560例匹配对照者。分析心脏骤停与血清钙、透析液钙、血清-透析液钙浓度梯度、QT间期延长药物的相关性

  美国一项研究表明,低钙透析液、血清-透析液钙浓度梯度较大与心脏骤停风险增加相关。该论文发表于《美国肾脏病学会临床杂志》[Clin J Am Soc Nephrol 2013,8(5):797]。

  该研究纳入血液透析者中510例心脏骤停者及1560例匹配对照者。分析心脏骤停与血清钙、透析液钙、血清-透析液钙浓度梯度、QT间期延长药物的相关性。

  结果为,低钙透析液组(<2.5 Eq/L)患者血清-透析液钙浓度梯度较大,透析过程中血压下降幅度较大。校正协变量及基线差异后,低钙透析液(<2.5 Eq/L)、纠正血清钙浓度较高、血清-透析液钙浓度梯度较大与心脏骤停风险增加相关,比值比(OR)分别为2.00、1.10和1.40。QT间期延长药物与心脏骤停风险增加无显著相关性。

原始出处:

Pun PH, Horton JR, Middleton JP.Dialysate calcium concentration and the risk of sudden cardiac arrest in hemodialysis patients. Clin J Am Soc Nephrol. 2013 May;8(5):797-803.



    

评论区 (2)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1941233, encodeId=1c0219412334b, content=<a href='/topic/show?id=bd2f28e0e1' target=_blank style='color:#2F92EE;'>#ASN#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2870, encryptionId=bd2f28e0e1, topicName=ASN)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1777154, createdName=chenhongpeng, createdTime=Sun May 19 19:34:00 CST 2013, time=2013-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1783222, encodeId=09911e8322216, content=<a href='/topic/show?id=2f7d4e816b' target=_blank style='color:#2F92EE;'>#CJASN#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4781, encryptionId=2f7d4e816b, topicName=CJASN)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f34c147, createdName=ay2000fy, createdTime=Sun Jun 16 17:34:00 CST 2013, time=2013-06-16, status=1, ipAttribution=)]
    2013-05-19 chenhongpeng

    #ASN#

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1941233, encodeId=1c0219412334b, content=<a href='/topic/show?id=bd2f28e0e1' target=_blank style='color:#2F92EE;'>#ASN#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2870, encryptionId=bd2f28e0e1, topicName=ASN)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1777154, createdName=chenhongpeng, createdTime=Sun May 19 19:34:00 CST 2013, time=2013-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1783222, encodeId=09911e8322216, content=<a href='/topic/show?id=2f7d4e816b' target=_blank style='color:#2F92EE;'>#CJASN#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4781, encryptionId=2f7d4e816b, topicName=CJASN)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f34c147, createdName=ay2000fy, createdTime=Sun Jun 16 17:34:00 CST 2013, time=2013-06-16, status=1, ipAttribution=)]
    2013-06-16 ay2000fy

    #CJASN#

    0